Key result
Mitral valve reconstruction matches mechanical valves for overall complications but is superior in isolated nonrheumatic disease.
Why the study?
Does mitral valve reconstruction improve long-term outcomes compared to mechanical valve replacement in patients with mitral insufficiency?
Cohort (n=1,239)
Does mitral valve reconstruction improve long-term outcomes compared to mechanical valve replacement in patients with mitral insufficiency?
Mitral valve reconstruction is preferable for isolated nonrheumatic mitral insufficiency, while mechanical valve replacement offers better outcomes for patients with multiple valve disease.
Answers are grounded in this paper and cite their sources.
May favor mitral reconstruction in isolated nonrheumatic disease; leaves open confirmation by randomized trials.
OBJECTIVES: Although many advantages of mitral valve reconstruction have been demonstrated, whether specific subgroups of patients exist in whom mechanical valve replacement offers advantages over mitral reconstruction remains undetermined. METHODS: This study examined the late results of mitral valve surgery in patients with mitral insufficiency who received either a St. Jude Medical valve (n = 514) or a mitral valve reconstruction with ring annuloplasty (n = 725) between 1980 and 1996. RESULTS: Overall operative mortality was 7.2% in the patients receiving a St. Jude Medical mitral valve and 5.4% in those undergoing mitral valve reconstruction (no significant difference); isolated mortality was 2.5% in the St. Jude Medical group and 2.2% in the valve reconstruction group (no significant difference). The follow-up interval was more than 5 years for 340 patients with a mean of 39.8 months (98.5% complete). Overall 8-year freedom from late cardiac death, reoperation, and all valve-related complications was 72.8% for the St. Jude Medical group and 64.8% for valve reconstruction group (no significant difference). For patients with isolated, nonrheumatic mitral valve disease, 8-year freedom from late cardiac death and reoperation was better in the mitral valve reconstruction group (88.3%) than in the St. Jude Medical valve group (86.0%; p = 0.05). Furthermore, Cox proportional hazards regression revealed that mitral valve reconstruction was independently associated with a lesser incidence of late cardiac death (p = 0.04), irrespective of preoperative New York Heart Association class. However, the St. Jude Medical valve offered better 8-year freedom from late cardiac death, reoperation, and all valve-related complications than did mitral valve reconstruction in patients with multiple valve disease (77.0% vs 45.3%; p < 0.01). CONCLUSIONS: Therefore, mitral valve reconstruction appears to be the procedure of choice for isolated, nonrheumatic disease, whereas insertion of a St. Jude Medical valve should be preferred for patients with multiple valve disease.
No takes yet. Share an insight, caveat, or question.
Grossi et al. (1998) conducted a cohort in Mitral insufficiency (n=1,239). Mitral valve reconstruction with ring annuloplasty vs. St. Jude Medical valve replacement was evaluated on Overall 8-year freedom from late cardiac death, reoperation, and all valve-related complications (p=no significant difference). Mitral valve reconstruction had similar 8-year freedom from complications as St. Jude valve replacement, but was superior in isolated nonrheumatic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: